Leqembi TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: lecanemab
Brand name
(ARTG)
: LEQEMBI lecanemab 200 mg/2 mL concentrated injection vialConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
LEQEMBI is indicated in adult patients with a diagnosis of mild cognitive impairment and mild dementia due to Alzheimers disease (Early Alzheimers disease) that are apolipoprotein E epsilon 4 (ApoE epsilon 4) non-carriers or heterozygotes.,Beta amyloid evidence consistent with Alzheimers disease (AD) should be confirmed using a validated test prior to initiating treatment.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, concentrated
- Intravenous Infusion
- A clear to opalescent, colourless to pale yellow solution filled into a clear glass vial, closed with a rubber stopper, and sealed with an aluminum closure with a dark grey flip-off button
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Do not Freeze
- Refrigerate
- Do not Shake
- Shelf lifetime is 24 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 vial pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lecanemab
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
